Reliance is one of the focus topics of the International Pharmaceuticals Regulators Programme (IPRP) and is strongly supported by the IPRP members.
Use of reliance approaches means moving to a more innovative, effective way of working, based on trust and relying on the outputs of other national regulatory authorities (NRAs). Reliance is relevant for all resource settings.
Leveraging the output of other regulators makes the global regulatory oversight more efficient and helps the work of regulators, allowing the allocation of resources to value-added regulatory functions, that cannot be undertaken by other authorities. In addition, reliance can result in more evidence-based, better-quality decisions by making the best use of the global expertise and can increase the efficiency of a regulatory system in a country or region.